Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lomond Therapeutics Holdings, Inc.

Clinical trials sponsored by Lomond Therapeutics Holdings, Inc., explained in plain language.

Trials to join now! 2 Not yet recruiting 1 Completed 2

New drug combo tested for Tough-to-Treat blood cancer

Disease control Not yet recruiting

This early-stage study is testing a new two-drug combination (lonitoclax and azacitidine) for adults whose acute myeloid leukemia has returned or hasn't responded to prior treatments. The main goals are to find a safe and effective dose and to see how well the body handles the dr…

Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC